IRON Strangle Strategy
IRON (Disc Medicine, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
IRON (Disc Medicine, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.68B, a beta of 2.14 versus the broader market, a 52-week range of 40-99.5, average daily share volume of 587K, a public-listing history dating back to 2020, approximately 94 full-time employees. These structural characteristics shape how IRON stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.14 indicates IRON has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on IRON?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current IRON snapshot
As of May 15, 2026, spot at $66.80, ATM IV 60.10%, IV rank 11.59%, expected move 17.23%. The strangle on IRON below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on IRON specifically: IRON IV at 60.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a IRON strangle, with a market-implied 1-standard-deviation move of approximately 17.23% (roughly $11.51 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IRON expiries trade a higher absolute premium for lower per-day decay. Position sizing on IRON should anchor to the underlying notional of $66.80 per share and to the trader's directional view on IRON stock.
IRON strangle setup
The IRON strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IRON near $66.80, the first option leg uses a $70.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IRON chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IRON shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $70.00 | $3.78 |
| Buy 1 | Put | $65.00 | $3.65 |
IRON strangle risk and reward
- Net Premium / Debit
- -$742.50
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$742.50
- Breakeven(s)
- $57.58, $77.43
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
IRON strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on IRON. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$5,756.50 |
| $14.78 | -77.9% | +$4,279.63 |
| $29.55 | -55.8% | +$2,802.75 |
| $44.32 | -33.7% | +$1,325.88 |
| $59.08 | -11.5% | -$151.00 |
| $73.85 | +10.6% | -$357.13 |
| $88.62 | +32.7% | +$1,119.75 |
| $103.39 | +54.8% | +$2,596.62 |
| $118.16 | +76.9% | +$4,073.49 |
| $132.93 | +99.0% | +$5,550.37 |
When traders use strangle on IRON
Strangles on IRON are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the IRON chain.
IRON thesis for this strangle
The market-implied 1-standard-deviation range for IRON extends from approximately $55.29 on the downside to $78.31 on the upside. A IRON long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current IRON IV rank near 11.59% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IRON at 60.10%. As a Healthcare name, IRON options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IRON-specific events.
IRON strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IRON positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IRON alongside the broader basket even when IRON-specific fundamentals are unchanged. Always rebuild the position from current IRON chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on IRON?
- A strangle on IRON is the strangle strategy applied to IRON (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With IRON stock trading near $66.80, the strikes shown on this page are snapped to the nearest listed IRON chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IRON strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the IRON strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 60.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$742.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IRON strangle?
- The breakeven for the IRON strangle priced on this page is roughly $57.58 and $77.43 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IRON market-implied 1-standard-deviation expected move is approximately 17.23%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on IRON?
- Strangles on IRON are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the IRON chain.
- How does current IRON implied volatility affect this strangle?
- IRON ATM IV is at 60.10% with IV rank near 11.59%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.